Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00419
|
|||||
Drug Name |
Escitalopram
|
|||||
Synonyms |
(+)-(S)-1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile; (1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile; (1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile; (S)-Citalopram; Cipralex (TN); Escitalopram (INN); Escitalopram [INN]; Esertia; Esertia (TN); Lexapro (TN); S(+)-Citalopram
|
|||||
Drug Type |
Small molecular drug
|
|||||
Therapeutic Class |
Antidepressants
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C20H21FN2O
|
|||||
Canonical SMILES |
CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
|
|||||
InChI |
InChI=1S/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3/t20-/m0/s1
|
|||||
InChIKey |
WSEQXVZVJXJVFP-FQEVSTJZSA-N
|
|||||
CAS Number |
CAS 128196-01-0
|
|||||
Pharmaceutical Properties | Molecular Weight | 324.4 | Topological Polar Surface Area | 36.3 | ||
Heavy Atom Count | 24 | Rotatable Bond Count | 5 | |||
Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 4 | |||
XLogP |
3.2
|
|||||
PubChem CID | ||||||
PubChem SID |
10249284
, 103558387
, 104156586
, 104414365
, 11110983
, 11114081
, 11364295
, 11366857
, 11369419
, 11371963
, 11374782
, 11377581
, 11484357
, 11488367
, 11490877
, 11493026
, 11495215
, 124879737
, 124879740
, 126525322
, 126626833
, 126667435
, 126669969
, 127339776
, 127339777
, 127339778
, 135103622
, 137002472
, 141023772
, 141191354
, 14777200
, 14826334
, 160964509
, 163124265
, 164834640
, 172914696
, 17425394
, 46223778
, 46507040
, 47736762
, 48185248
, 50067335
, 50100207
, 50123207
, 57346404
, 80123692
, 85789669
, 92308964
, 93167153
, 96024609
|
|||||
ChEBI ID |
ChEBI:36791
|
|||||
TTD Drug ID |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.